Clinical Trial Update: Study of MEDI-507 Administered by Intravenous Infusion to Adults With Plaque Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of MEDI-507 given by intravenous infusion in adults with plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• MEDI-507

Snippet

Sponsor: MedImmune LLC | Conditions: Psoriasis | Phase 2 | Status: COMPLETED